Skip to content

TagCirculating

Researchers led by UC San Diego develop a non-invasive blood test capable of detecting circulating tumor DNA methylation to identify whether a person has one of the five most prevalent forms of cancers, up to four years before diagnosis. The team states their diagnostic can detect cancer by targeting a limited number of genomic regions aberrantly methylated across different cancer types, allowing it to be used as an inexpensive cancer screen from only a single vial of blood, unlike the more costly ctDNA which works by identifying a legion of inconsistent mutations.

Non-invasive blood test can detect cancer four years before diagnosis.

The leading cause of death worldwide, cancer killed at least 7.6 million people in 2008, accounting for a staggering thirteen percent of all deaths globally. With no signs of abating, … Continue Reading Non-invasive blood test can detect cancer four years before diagnosis.

Researchers successfully block circulating breast cancer cells from entering bones.

Breast cancer is notorious for its ability to relapse after many years, long after a patient had completed treatment.  A major site of disease dissemination and relapse is bone, although … Continue Reading Researchers successfully block circulating breast cancer cells from entering bones.

Translate »